Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers

European Thyroid Journal · Published 2026-04-13 · DOI 10.1530/etj-25-0301

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1530/etj-25-0301

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Predicting dysthyroid optic neuropathy in moderate-to-severe thyroid eye disease: a clinically applicable nomogram · European Thyroid Journal · 2025 · Same journal
• Can back-wall cystic figures of thyroid nodules predict benignity? · European Thyroid Journal · 2025 · Same journal
• EUthyroid2: The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe and beyond · European Thyroid Journal · 2025 · Same journal
• The caprices of a trace element: selenium’s considerable effects on Hashimoto’s thyroiditis, though few on Graves’ disease · European Thyroid Journal · 2026 · Same journal
• CD8+ T cells in Hashimoto’s thyroiditis-associated papillary thyroid carcinoma · European Thyroid Journal · 2026 · Same journal
• External validation of a microRNA thyroid classifier: a real-world prospective study · European Thyroid Journal · 2025 · Same journal
• Single-cell RNA sequencing: a powerful tool to study heterogeneity in papillary and anaplastic thyroid carcinoma · European Thyroid Journal · 2026 · Same journal
• High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids · European Thyroid Journal · 2026 · Same journal
• Hypercalcitoninemia in chronic kidney disease: an old issue, a new perspective? · European Thyroid Journal · 2026 · Same journal
• Habitat imaging based on water–fat separation for interpreting extraocular muscle heterogeneity in thyroid eye disease · European Thyroid Journal · 2026 · Same journal